GLP-1s are building a reputation as "wonder drugs." First characterized for their ability to improve insulin release and treat diabetes, the drugs...

GLP-1s are building a reputation as "wonder drugs." First characterized for their ability to improve insulin release and treat diabetes, the drugs...

Potentially giving it an early start in a key market after Novo Nordisk A/S’s Ozempic patent expired. ......

Potentially giving it an early start in a key market after Novo Nordisk A/S’s Ozempic patent expired. ......

GLP-1 agonist market expected to grow from $70B in 2025 to $201B in 20301 Proprietary Forzet formulation provides pharmacists, physicians and patients...

GLP-1 agonist market expected to grow from $70B in 2025 to $201B in 20301 Proprietary Forzet formulation provides pharmacists, physicians and patients...

A lack of vitamin B2 makes tumour cells more susceptible to a unique form of cell death. This was discovered by researchers at the Rudolf Virchow...

Type 1 diabetes is a serious disease that affects how the body controls sugar in the blood. People with this condition cannot produce enough insulin,...

Type 1 diabetes is a serious disease that affects how the body controls sugar in the blood. People with this condition cannot produce enough insulin,...

Researchers have discovered that an existing drug could be the breakthrough cure for a condition impacting 30 million people in the US, which until...